Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Celgene Corporation (CELG)

108.24   0.11 (0.1%) 11-20 16:00
Open: 108.01 Pre. Close: 108.13
High: 108.59 Low: 107.27
Volume: 191,230,586 Market Cap: 77036M
Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 108.37 - 109.047 109.047 - 109.525
Low: 106.592 - 107.459 107.459 - 108.07
Close: 107.111 - 108.37 108.37 - 109.257

Technical analysis

as of: 2019-12-13 4:29:38 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 129.30     One year: 151.02
Support: Support1: 104.40    Support2: 100.50
Resistance: Resistance1: 110.70    Resistance2: 129.30
Pivot: 108.91
Moving Average: MA(5): 109.60     MA(20): 108.01
MA(100): 98.50     MA(250):
MACD: MACD(12,26): 1.98     Signal(9): 2.24
Stochastic oscillator: %K(14,3): 68.58     %D(3): 81.10
RSI: RSI(14): 61.15
52-week: High: 110.70  Low: 58.59  Change(%): 48.7
Average Vol(K): 3-Month: 395739  10-Days: 588374

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CELG has closed above bottom band by 33.1%. Bollinger Bands are 25% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 12 Feb 2020 12:00:00 +0000
Better Buy: bluebird bio vs. Gilead Sciences

Tue, 21 Jan 2020 20:46:00 +0000
Merck's Keytruda Could Face Direct Competition from New Chinese Drug

Mon, 06 Jan 2020 04:26:40 +0000
Here's Why Bristol-Myers Squibb Jumped 12.7% in December

Mon, 16 Dec 2019 14:55:41 +0000
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?

Tue, 19 Nov 2019 14:02:27 +0000
Technology Sector Update for 11/19/2019: JKS, NOW, CELG, BMY, BILI, MSFT, AAPL, IBM, CSCO, GOOG

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E
P/E Growth Ratio
P/BV
P/S -10000000000.00
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.